STOP Fentanyl Overdoses Act of 2023
- Last Action
- 5/19/2023
Actions
- 2023-05-19Referred to the Subcommittee on Health.
- 2023-05-16Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-05-16Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-05-16Introduced in House
- 2023-05-16Introduced in House
CRS Summary
As of 2023-05-16 (00)
Support, Treatment, and Overdose Prevention of Fentanyl Overdoses Act of 2023 or the STOP Fentanyl Overdoses Act of 2023
This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances.
Specifically, the bill expands surveillance of fentanyl and related substances. This includes requiring a study on how to track overdoses by type of drug (including fentanyl) and awarding grants to states for collecting data about fentanyl-involved overdoses. The bill also provides for (1) training on detecting and handling fentanyl for law enforcement, and (2) grants for forensic laboratories to facilitate surveillance of controlled substances seized by law enforcement.
Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also establishes grants and requires other efforts to expand access to medications that temporarily reverse opioid overdoses (e.g., naloxone) and related harm reduction activities.
Furthermore, the bill extends, subject to some conditions, liability protections for those who administer aid in an emergency (commonly known as Good Samaritan laws) to individuals who administer opioid overdose reversal drugs and to individuals who seek medical attention for themselves or on behalf of another for a drug overdose.
The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.
Cosponsors (20)
- Lisa Blunt Rochester (D-DE)
- Don Bacon (R-NE)
- Paul Tonko (D-NY)
- David Trone (D-MD)
- Jimmy Panetta (D-CA)
- Lori Trahan (D-MA)
- Colin Allred (D-TX)
- Angie Craig (D-MN)
- Brittany Pettersen (D-CO)
- Nanette Barragan (D-CA)
- Donald Norcross (D-NJ)
- Tony Cárdenas (D-CA)
- Hillary Scholten (D-MI)
- Nikki Budzinski (D-IL)
- Sean Casten (D-IL)
- Terri Sewell (D-AL)
- Chrissy Houlahan (D-PA)
- Nikema Williams (D-GA)
- Chellie Pingree (D-ME)
- William Keating (D-MA)
Subjects
- Civil actions and liability
- Congressional oversight
- Correctional facilities and imprisonment
- Customs enforcement
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Federal preemption
- Government information and archives
- Government studies and investigations
- Health care costs and insurance
- Health care coverage and access
- Health information and medical records
- Health promotion and preventive care
- Intelligence activities, surveillance, classified information
- Intergovernmental relations
- Law enforcement administration and funding
- Medical research
- Mental health
- Research administration and funding
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.